MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
GOVX GeoVax Labs
- 2.2900
- -0.0300-1.29%
Close Dec 20 16:00 ET
- 2.2705
- -0.0195-0.85%
Post 20:01 ET
21.61MMarket Cap-0.27P/E (TTM)
2.3797High2.1901Low641.63KVolume2.3100Open2.3200Pre Close1.47MTurnover7.60%Turnover RatioLossP/E (Static)9.44MShares11.180052wk High2.54P/B19.34MFloat Cap1.090152wk Low--Dividend TTM8.45MShs Float130.6500Historical High--Div YieldTTM8.17%Amplitude1.0900Historical Low2.2910Avg Price1Lot Size
About GeoVax Labs Company
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Company Profile
SymbolGOVX
Company NameGeoVax Labs
Listing DateSep 25, 2020
Founded1988
CEOMr. David A. Dodd
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address1900 Lake Park Drive,Suite 380
CitySmyrna
ProvinceGeorgia
CountryUnited States of America
Zip Code30080
Phone1-678-384-7220
Websitehttp://www.geovax.com
Company Executives
- Name
- Position
- Salary
- David A. Dodd
- Chairman of the Board, Chief Executive Officer and President
- 384.20K
- Dr. Kelly T. McKee, M.D.
- Chief Medical Officer
- 361.03K
- Mark W. Reynolds, C.P.A.
- Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
- --
- Dr. Mark J. Newman, PhD
- Chief Scientific Officer
- 291.50K
- Dr. John W. Sharkey, PhD
- Vice President, Business Development
- --
- Nicole Lemerond
- Independent Director
- 32.50K
- Dean G. Kollintzas
- Independent Director
- 37.50K
- Dr. Robert T. McNally,PhD
- Lead Independent Director
- 47.50K
- Dr. Jayne Morgan, M.D.
- Independent Director
- 30.00K
- John N. Spencer, Jr., C.P.A.
- Independent Director
- 45.00K
- Dr. Randal D. Chase, PhD
- Independent Director
- 47.50K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
